Post-IPO Equity Therapeutics Companies

Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.

Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.

Psyence develops natural psilocybin products for the treatment of psychological trauma and mental health disorders

BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

Klotho Neurosciences develops disease modifying therapies for age-related cognitive and neurodegenerative disorders and cancer.

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Prokidney provide specialized treatment for chronic kidney disease.

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Abivax develops medicines that alter the body's natural immune system mechanisms.

Avalo Therapeutics is a clinical-stage biopharmaceutical company.

IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain.

CNS Pharmaceutical is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company utilizing proprietary technology to develop novel therapies.

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

Elicera Therapeutics develops cell and gene therapies for cancer treatment, with a focus on CAR T-cell therapies and oncolytic viruses.

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases